Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) - Total Liabilities
Based on the latest financial reports, Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) has total liabilities worth CN¥660.73 Million CNY (≈ $96.69 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Jilin Jian Yisheng Pharmaceutical Co Ltd's assets to evaluate the company's liquid asset resilience ratio.
Jilin Jian Yisheng Pharmaceutical Co Ltd - Total Liabilities Trend (2006–2025)
This chart illustrates how Jilin Jian Yisheng Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 002566 total asset value.
Jilin Jian Yisheng Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Jilin Jian Yisheng Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Thaicom Public Company Limited
BK:THCOM
|
Thailand | ฿5.46 Billion |
|
Argo Global Listed Infrastructure Ltd
AU:ALI
|
Australia | AU$28.34 Million |
|
Lendingtree Inc
NASDAQ:TREE
|
USA | $590.86 Million |
|
Tiv Taam
TA:TTAM
|
Israel | ILA1.16 Billion |
|
Guangdong TianYiMa Information Industry Co.Ltd.
SHE:301178
|
China | CN¥660.85 Million |
|
Selena FM S.A.
WAR:SEL
|
Poland | zł667.99 Million |
|
CHEERWIN GRP. -0000002
F:1RQ
|
Germany | €624.31 Million |
|
Public Policy Holding Company, Inc. Common Stock
NASDAQ:PPHC
|
USA | $129.81 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down Jilin Jian Yisheng Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Jilin Jian Yisheng Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.86 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jilin Jian Yisheng Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jilin Jian Yisheng Pharmaceutical Co Ltd (2006–2025)
The table below shows the annual total liabilities of Jilin Jian Yisheng Pharmaceutical Co Ltd from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥630.35 Million ≈ $92.24 Million |
-1.08% |
| 2024-12-31 | CN¥637.22 Million ≈ $93.25 Million |
-10.79% |
| 2023-12-31 | CN¥714.30 Million ≈ $104.52 Million |
-0.40% |
| 2022-12-31 | CN¥717.18 Million ≈ $104.95 Million |
+7.67% |
| 2021-12-31 | CN¥666.08 Million ≈ $97.47 Million |
+0.33% |
| 2020-12-31 | CN¥663.86 Million ≈ $97.14 Million |
+51.34% |
| 2019-12-31 | CN¥438.66 Million ≈ $64.19 Million |
-25.33% |
| 2018-12-31 | CN¥587.49 Million ≈ $85.97 Million |
-22.33% |
| 2017-12-31 | CN¥756.40 Million ≈ $110.69 Million |
-13.02% |
| 2016-12-31 | CN¥869.67 Million ≈ $127.26 Million |
-2.14% |
| 2015-12-31 | CN¥888.65 Million ≈ $130.04 Million |
+20.21% |
| 2014-12-31 | CN¥739.24 Million ≈ $108.17 Million |
+245.77% |
| 2013-12-31 | CN¥213.79 Million ≈ $31.28 Million |
+193.62% |
| 2012-12-31 | CN¥72.81 Million ≈ $10.65 Million |
+12.86% |
| 2011-12-31 | CN¥64.52 Million ≈ $9.44 Million |
-58.55% |
| 2010-12-31 | CN¥155.66 Million ≈ $22.78 Million |
+6.13% |
| 2009-12-31 | CN¥146.67 Million ≈ $21.46 Million |
+15.10% |
| 2008-12-31 | CN¥127.43 Million ≈ $18.65 Million |
-6.35% |
| 2007-12-31 | CN¥136.08 Million ≈ $19.91 Million |
+36.97% |
| 2006-12-31 | CN¥99.35 Million ≈ $14.54 Million |
-- |
About Jilin Jian Yisheng Pharmaceutical Co Ltd
Jilin Jian Yisheng Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, wholesale, retail, import, and export of pharmaceutical products in China. The company offers paper packaging products; drugs comprising capsules, injections, tablets, granules, and other drug products; cosmetics; ginseng products; bee products; and food products comprisi… Read more